Literature DB >> 14749705

CD38 expression on B-cell chronic lymphocytic leukemic cells is strongly correlated with vascular endothelial growth factor expression.

D McCabe, L Bacon, K O'Regan, C Condron, J R O'Donnell, P T Murphy.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14749705     DOI: 10.1038/sj.leu.2403282

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  4 in total

1.  Genetic modification of primary chronic lymphocytic leukemia cells with a lentivirus expressing CD38.

Authors:  Laurence Pearce; Liam Morgan; Thet Thet Lin; Saman Hewamana; R James Matthews; Silvia Deaglio; Clare Rowntree; Christopher Fegan; Christopher Pepper; Paul Brennan
Journal:  Haematologica       Date:  2010-03       Impact factor: 9.941

2.  FCR and bevacizumab treatment in patients with relapsed chronic lymphocytic leukemia.

Authors:  Preetesh Jain; Hun Ju Lee; Wei Qiao; William Wierda; Ohad Benjamini; Jan Burger; Alessandra Ferrajoli; Zeev Estrov; Hagop Kantarjian; Michael Keating; Susan O'Brien
Journal:  Cancer       Date:  2014-07-15       Impact factor: 6.860

3.  Physical contact with endothelial cells through β1- and β2- integrins rescues chronic lymphocytic leukemia cells from spontaneous and drug-induced apoptosis and induces a peculiar gene expression profile in leukemic cells.

Authors:  Rossana Maffei; Stefania Fiorcari; Jenny Bulgarelli; Silvia Martinelli; Ilaria Castelli; Silvia Deaglio; Giulia Debbia; Marcella Fontana; Valeria Coluccio; Goretta Bonacorsi; Patrizia Zucchini; Franco Narni; Giuseppe Torelli; Mario Luppi; Roberto Marasca
Journal:  Haematologica       Date:  2011-12-29       Impact factor: 9.941

Review 4.  Understanding the Immune-Stroma Microenvironment in B Cell Malignancies for Effective Immunotherapy.

Authors:  Benedetta Apollonio; Nikolaos Ioannou; Despoina Papazoglou; Alan G Ramsay
Journal:  Front Oncol       Date:  2021-03-25       Impact factor: 6.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.